Antimicrobial drug resistance in non-typhi Salmonellae in Castilia y León;Resistencia a antimicrobianos en Salmonella no typhi en Castilla y León

Revista Espanola de Quimioterapia

Volumn 17, Issue 1, 2004, Pages 29-36

  Delgado Ronda, N ^a   Munoz Bellido J L ^a,b   Ibanez Perez R ^c   Garcia Garcia M I ^a,b   Serrano Heranz, R ^c   Munoz Criado S ^a,b   Garcia Rodriguez J A ^a,b  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^c HOSPITAL NUESTRA SEÑORA DE SONSOLES   (Spain)

Author keywords

Antibiotics; Castilla y Le n; Resistance; Salmonella

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; AZTREONAM; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLOTRIMAZOLE; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MOXIFLOXACIN; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; SULFAMETHOXAZOLE; SULFONAMIDE; TETRACYCLINE; TETRACYCLINE DERIVATIVE;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; COMPARATIVE STUDY; CONTROLLED STUDY; GEOGRAPHIC DISTRIBUTION; NONHUMAN; PHENOTYPE; SALMONELLA; SALMONELLA ENTERITIDIS; SALMONELLA TYPHIMURIUM; SEROTYPE; STRAIN DIFFERENCE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; SALMONELLA; SPAIN;

EID: 2542440634     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Cormican, M., Butler, C., Morris, D., Corbett-Feeney, G., Flynn, J. Antibiotic resistance amongst Salmonella enterica species isolated in the Republic of Ireland. J Antimicrob Chemother 1998; 42: 116-118.
2. Angulo, F., Griffin, P. Changes in antimicrobial resistance in Salmonella enterica serovar typhimurium. Emerg Infect Dis 2000; 6: 436.
3. Davis, M., Hancock, D., Beeser, T. y cols. Changes in antimicrobial resistance among Salmonella enterica serovar typhimurium isolates from humans and cattle in the northwestern United States, 1982-1997. Emerg Infect Dis 1999; 5: 802.
4. Ridley, A., Threlfall, E. Molecular epidemiology of antibiotic resistance genes in multiresistant epidemic Salmonella typhimurium DT104. Microb Drug Resist 1998; 4: 2.
5. Briggs, C., Fratamico, P. Molecular characterizacion of an antibiotic resistance gene cluster of Salmonella typhimurium DT 104. Antimicrob Agents Chemother 1999; 43: 846-849.
6. Arcangioli, M., Leroy-Sétrin, S., Martel, J., Chaslus-Dancla, E. A new chloranphenicol and florfenicol resistance gene flanked by two integron structures in Salmonella typhimurium DT 104. FEMS Microbiol Lett 1999; 174: 327-332.
7. Threlfall, E. Epidemic Salmonella typhimurium DT 104-a truly internacional multiresistant clone. J Antimicrob Chemother 2000; 46: 7-10.
8. Herikstad, H., Hayes, P., Mokhtar, M., Fracaro, M., Threlfall, E., Angulo, F. Emerging quinolone-resistant Salmonella in the United States. Emerg Infect Dis 1997; 3: 371.
9. Baraniak, A., Sadowy, E., Hryniewicz, W., Gniadkowski, M. Two different extended-spectrum β-lactamases (ESBLs) in one of the first ESBL-producing Salmonella isolates in Poland. J Clin Microbiol 2002; 40: 1095-1097.
10. Rankin, S., Aceto, H., Cassidy, J. y cols. Molecular characterization of cephalosporin-resistant Salmonella enterica serotype newport isolates from animals in Pennsylvania. J Clin Microbiol 2002; 40: 4679-4684.
11. Ferran, E., Pérez-Trallero, J., Marimón, R., Gomariz, M., Mirelis, B. CMY-2-producing Salmonella enterica, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis and Escherichia coli strains isolated in Spain (October 1999-December 2000). J Antimicrob Chemother 2001; 48: 383-389.
12. Bradford, P., Yang, Y., Sahm, D., Grope, I., Gardovska, D., Storch, G. CTX-M-5. A novel cefotaxime-hydrolyzing β-lactamase from an outbreak of Salmonella typhimurium in Latvia. Antimicrob Agents Chemother 1998; 42: 1980-1984.
13. Gazouli, M., Sidorenko, S., Tzelepi, E., Kozlova, N., Gladin, D., Tzouvelekis, L. A plasmid-mediated β-lactamase conferring resistance to cefotaxime in a Salmonella typhimurium clone found in St Petersburg, Russia. J Antimicrob Chemother 1998; 41: 119-121.
14. Miriagou, V., Tzouvelekis, L., Rossiter, S., Tzelepi, E., Angulo, F., Whichard, J. Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2. Antimicrob Agents Chemother 2003; 47: 1297-1300.
15. Armand-Lefèvre, L., Leflon-Guibout, V., Brendin, J. y cols. Imipenem resistance in Salmonella enterica serovar wien related to porin Loss and CMY-4 β-lactamase production. Antimicrob Agents Chemother 2003; 47: 1165-1168.
16. Balis, E., Vatopoulos, A., Kanelopoulou, M. y cols. Indications of in vivo transfer of an epidemic R plasmid from Salmonella enteritidis to Escherichia coli of the normal human gut flora. J Clin Microbiol 1996; 34: 977-979.
17. Diez, P., Calderón, V. Empleo de antibióticos en veterinaria. Rev Esp Quimioterap 1997; 10: 275-280.
18. McEwen, S., Fedorka-Cray, P. Antimicrobial use and resistance in animals. Clin Infect Dis 2002; 34: S93-S106.
19. O'Brien, T. Emergence, spread and environmental effect of antimicrobial resistance: How use of an antimicrobial anywhere can increase resistance to any antimicrobial anywhere else. Clin Infect Dis 2002; 34: S78-S84.
20. Cancho, B., García, M., Simal, J. El uso de los antibióticos en la alimentación animal: Perspectiva actual. Cienc Tecnol Aliment 2000; 3: 39-47.
21. Angulo, F. Agentes antimicrobianos en acuicultura: Impacto potencial en la salud pública. Enferm Infecc Microbiol Clin 2000; 20: 217-219.
22. Fey, P., Safranek, T., Rupp, M. y cols. Ceftriaxone-resistant Salmonella infection adquired by a child from cattle. N Engl J Med 2000; 342: 1242-1249.
23. Griggs, D., Hall, M., Jin, Y., Piddock, L. Quinolone resistance in veterinary isolates of Salmonella. J Antimicrob Chemother 1994; 33: 1173-1189.
24. Orden, J., de la Fuente, R. Repercusiones en la salud pública de la resistencia a quinolonas en bacterias de origen animal. Rev Esp Salud Pública 2001; 75: 4.
25. Hakanen, A., Kotilainen, P., Jalava, J., Siitonen, A., Huovinen, P. Detection of decreased fluorquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test. J Clin Microbiol 1999; 37: 3572-2577.
26. Griggs, D., Gensberg, K., Piddock, L. Mutations in gyrA gene of quinolone-resistant Salmonella serotypes isolated from humans and animals. Antimicrob Agents Chemother 1996; 40: 1009-1013.
27. Piddock, L., Ricci, V., McLaren, I., Griggs, D. Role of mutation in the gyrA and parC genes of nalidixic-acid resistant Salmonella serotypes isolated from animals in the United Kingdom. J Antimicrob Chemother 1998; 41: 635-641.
28. Molbak, K., Gerner-Smitdt, P., Wegener, H. Increasing quinolone resistance in Salmonella enterica serotype enteritidis. Emerg Infect Dis 2002; 8: 514.
29. Mesa Española de Normalización de la Sensibilidad y Resistencia a los Antimicrobianos (MENSURA). Recomendaciones del Grupo MENSURA para la selección de antimicrobianos en el estudio de la sensibilidad y criterios para la interpretación del antibiograma. Rev Esp Quimioterap 2000; 13: 73-86.
30. Vasallo, F., Martín-Rabadán, P., Alcalá, L., García-Lechuz, J., Rodríguez-Créixems, M., Bouza, E. Failure of ciprofloxacin therapy for invasive nontyphoidal salmonellosis. Clin Infect Dis 1998; 26: 534-535.
31. Crump, J., Barret, T., Nelson, J., Angulo, F. Reevaluating fluorquinolone breakpoints for Salmonella enterica serotype typhi and for nontyphi salmonellae. Antimicrob Resist 2003; 37: 75-81.
32. Moller, F., Wiuff, C., Molbak, K., Threfall, E. Is the time to change fluorquinolone breakpoints for Salmonella spp? Antimicrob Agents Chemother 2003; 47: 827-829.
33. Threlfall, E., Ward, L., Skinner, J., Smith, H., Lacey, S. Ciprofloxacin-resistant Salmonella typhi and treatment failure. Lancet 1999; 353: 1590-1591.
34. Hohmann, E. Nontyphoidal salmonellosis. Clin Infect Dis 2001; 32: 263-269.
35. Cruchaga, S., Echeita, A., Aladueña, A., García-Peña, J., Frias, N., Usera, M. Antimicrobial resistance in salmonellae from humans, food and animals in Spain in 1998. J Antimicrob Chemother 2001; 47: 315-321.
36. Breuil, J., Brisabois, A., Casin, I., Armand-Lefèvre, L., Frémy, S., Collatz, E. Antibiotic resistance in Salmonellae isolated from humans and animals in France: Comparative data from 1994 and 1997. J Antimicrob Chemother 2000; 46: 965-971.
37. Gil-Setas, A., Mazón, A., Martín, C., Urtiaga, M., Inza, M. Salmonelosis no tifoidea en un área de salud de Navarra, España. Rev Esp Salud Pública 2002; 76: 49-56.
38. Olivera, S., Castillo, F., Lorente, M. Resistencia antibiótica en cepas clínicas de Salmonella enterica aisladas en Zaragoza. Rev Esp Quimioterap 2002; 15: 152-157.
39. Sirvent, E., Ruiz, M., Rodríguez, J., Royo, G. Serotipos y sensibilidad antibiótica del género Salmonella en Elche. Rev Esp Quimioterap 2002; 15: 55-60.
40. Chopra, I., Roberts, M. Tetracycline antibiotics: Mode de action, applications, molecular biology and epidemiology of bacterial resistance. Microbiol Molec Biol 2001; 65: 232-260.
41. Frech, G., Schwarz, S. Tetracycline resistance in Salmonella enterica subsp. enterica serovar Dublin. Antimicrob Agents Chemother 1998; 42: 288.
42. Bolton, L., Kelley, L., Lee, M., Fedorka-Cray, P., Maurer, J. Detection of multidrug-resistant Salmonella enterica serotype typhimurium DT 104 based on a gene which confers cross-resistance to florfenicol and chloramphenicol. J Clin Microbiol 1999; 37: 1348.
43. Galllot, O., Clemént, C., Simonet, M., Philippon, A. Novel transferable β-lactam resistance with cephalosporinase characteristic in Salmonella enteritidis. J Antimicrob Chemother 1997; 39: 85-88.
44. Koeck, J.L., Arlet, G., Philippon, A. y cols. A plasmid-mediated CMY-2 β-lactamase from Algerian clinical isolate of Salmonella seftenberg. FEMS Microbiol Lett 1997; 152: 255-260.
45. Morosini, M., Alaya, J., Baquero, F., Martínez, J., Blázquez, J. Biological cost of AmpC production for Salmonella enterica serotype typhimurium. Antimicrob Agents Chemother 2000; 4: 31-37.
46. Mhand, R., Brahimi, N., Moustaqui, N. Characterization of extended-spectrum β-lactamase-producing Salmonella typhimurium by phenotypic and genotypic typing methods. J Clin Microbiol 1999; 37: 3769-3773.
47. CTX-M-2 in Salmonella enterica serovar infantis. Antimicrob Agents Chemother 2002; 46: 2257-2261.
48. Koeck, J., Arlet, G., Philippon, A. y cols. A plasmid-mediated CMY-2 lactamase from an Algerian clinical isolate of Salmonella seftenberg. FEMS Microbiol Lett 1997; 152: 255-260.
49. Miriagou, V., Filip, R., Coman, G., Tzouvelekis, L. Expanded-spectrum cephalosporin-resistant Salmonella strains in Romania. Clin Microbiol 2002; 40: 4334-4336.
50. Llanes, C., Kirchgesner, V., Plesiat, P. Propagation of TEM-and PSE-type β-lactamases among amoxicillin-resistant Salmonella spp. isolated in France. Antimicrob Agents Chemother 1999; 43: 2430-2436.
51. Tassios, P., Gazouli, M., Tzelepi, E. y cols. Spread of a Salmonella typhimurium clone resistant to expanded-spectrum cephalosporins in three european countries. J Clin Microbiol 1999; 37: 3774-3777.
52. Villa, L., Mammina, C., Miriagou, V. Multidrug and broad-spectrum cephalosporin resistance among Salmonella enterica serotype enteritidis clinical isolates in southern Italy. J Clin Microbiol 2002; 40: 2662-2665.
53. Liebana, E., Clouting, C., Cassar, C. y cols. Comparison of gyrA mutations, cyclohexane resistance and the presence of class I integrons in Salmonella enterica from farm animals in England and Wales. J Clin Microbiol 2002; 40: 1481-1486.
54. Giraud, E., Cloeckaert, A., Kerboeuf, D., Chaslus-Dancla, E. Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar typhimurium. Antimicrob Agents Chemother 2002; 44: 1223-1228.
55. Randall, L., Cooles, S., Sayers, A., Woodward, M. Association between cyclohexane resistance in Salmonella of different serovars and increased resistance to multiple antibiotics, disinfectants and dyes. J Med Microbiol 2001; 50: 919-924.
56. Nikaido, H. Multiple antibiotic resistance and efflux. Curr Opin Microbiol 1998; 1: 516-523.